PharmaShots | Incisive News in 3 Shots

Subscribe Now

Abata Therapeutics

Abata Therapeutics Reports the US FDA’s IND Clearance for P-I Trial of ABA-101 for Progressive Multiple Sclerosis

Abata Therapeutics Reports the US FDA’s IND Clearance for P-I Trial of ABA-101 for Progressive Multiple Sclerosis

July 9, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us